2022-02-012023-01-312023-01-31false05194013DOVE CARE LIMITED2023-09-0686900iso4217:GBPxbrli:pure051940132022-02-01051940132023-01-31051940132022-02-012023-01-31051940132021-02-01051940132022-01-31051940132021-02-012022-01-3105194013bus:SmallEntities2022-02-012023-01-3105194013bus:AuditExempt-NoAccountantsReport2022-02-012023-01-3105194013bus:FullAccounts2022-02-012023-01-3105194013bus:PrivateLimitedCompanyLtd2022-02-012023-01-3105194013core:WithinOneYear2023-01-3105194013core:AfterOneYear2023-01-3105194013core:WithinOneYear2022-01-3105194013core:AfterOneYear2022-01-3105194013core:ShareCapital2023-01-3105194013core:SharePremium2023-01-3105194013core:RevaluationReserve2023-01-3105194013core:OtherReservesSubtotal2023-01-3105194013core:RetainedEarningsAccumulatedLosses2023-01-3105194013core:ShareCapital2022-01-3105194013core:SharePremium2022-01-3105194013core:RevaluationReserve2022-01-3105194013core:OtherReservesSubtotal2022-01-3105194013core:RetainedEarningsAccumulatedLosses2022-01-3105194013core:LandBuildings2023-01-3105194013core:PlantMachinery2023-01-3105194013core:Vehicles2023-01-3105194013core:FurnitureFittings2023-01-3105194013core:OfficeEquipment2023-01-3105194013core:NetGoodwill2023-01-3105194013core:IntangibleAssetsOtherThanGoodwill2023-01-3105194013core:ListedExchangeTraded2023-01-3105194013core:UnlistedNon-exchangeTraded2023-01-3105194013core:LandBuildings2022-01-3105194013core:PlantMachinery2022-01-3105194013core:Vehicles2022-01-3105194013core:FurnitureFittings2022-01-3105194013core:OfficeEquipment2022-01-3105194013core:NetGoodwill2022-01-3105194013core:IntangibleAssetsOtherThanGoodwill2022-01-3105194013core:ListedExchangeTraded2022-01-3105194013core:UnlistedNon-exchangeTraded2022-01-3105194013core:LandBuildings2022-02-012023-01-3105194013core:PlantMachinery2022-02-012023-01-3105194013core:Vehicles2022-02-012023-01-3105194013core:FurnitureFittings2022-02-012023-01-3105194013core:OfficeEquipment2022-02-012023-01-3105194013core:NetGoodwill2022-02-012023-01-3105194013core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3105194013core:ListedExchangeTraded2022-02-012023-01-3105194013core:UnlistedNon-exchangeTraded2022-02-012023-01-3105194013core:MoreThanFiveYears2022-02-012023-01-3105194013core:Non-currentFinancialInstruments2023-01-3105194013core:Non-currentFinancialInstruments2022-01-3105194013dpl:CostSales2022-02-012023-01-3105194013dpl:DistributionCosts2022-02-012023-01-3105194013dpl:AdministrativeExpenses2022-02-012023-01-3105194013core:LandBuildings2022-02-012023-01-3105194013core:PlantMachinery2022-02-012023-01-3105194013core:Vehicles2022-02-012023-01-3105194013core:FurnitureFittings2022-02-012023-01-3105194013core:OfficeEquipment2022-02-012023-01-3105194013core:NetGoodwill2022-02-012023-01-3105194013core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3105194013dpl:GroupUndertakings2022-02-012023-01-3105194013dpl:ParticipatingInterests2022-02-012023-01-3105194013dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3105194013core:ListedExchangeTraded2022-02-012023-01-3105194013dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3105194013core:UnlistedNon-exchangeTraded2022-02-012023-01-3105194013dpl:CostSales2021-02-012022-01-3105194013dpl:DistributionCosts2021-02-012022-01-3105194013dpl:AdministrativeExpenses2021-02-012022-01-3105194013core:LandBuildings2021-02-012022-01-3105194013core:PlantMachinery2021-02-012022-01-3105194013core:Vehicles2021-02-012022-01-3105194013core:FurnitureFittings2021-02-012022-01-3105194013core:OfficeEquipment2021-02-012022-01-3105194013core:NetGoodwill2021-02-012022-01-3105194013core:IntangibleAssetsOtherThanGoodwill2021-02-012022-01-3105194013dpl:GroupUndertakings2021-02-012022-01-3105194013dpl:ParticipatingInterests2021-02-012022-01-3105194013dpl:GroupUndertakingscore:ListedExchangeTraded2021-02-012022-01-3105194013core:ListedExchangeTraded2021-02-012022-01-3105194013dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-02-012022-01-3105194013core:UnlistedNon-exchangeTraded2021-02-012022-01-3105194013core:NetGoodwill2023-01-3105194013core:IntangibleAssetsOtherThanGoodwill2023-01-3105194013core:LandBuildings2023-01-3105194013core:PlantMachinery2023-01-3105194013core:Vehicles2023-01-3105194013core:FurnitureFittings2023-01-3105194013core:OfficeEquipment2023-01-3105194013core:AfterOneYear2023-01-3105194013core:WithinOneYear2023-01-3105194013core:ListedExchangeTraded2023-01-3105194013core:UnlistedNon-exchangeTraded2023-01-3105194013core:ShareCapital2023-01-3105194013core:SharePremium2023-01-3105194013core:RevaluationReserve2023-01-3105194013core:OtherReservesSubtotal2023-01-3105194013core:RetainedEarningsAccumulatedLosses2023-01-3105194013core:NetGoodwill2022-01-3105194013core:IntangibleAssetsOtherThanGoodwill2022-01-3105194013core:LandBuildings2022-01-3105194013core:PlantMachinery2022-01-3105194013core:Vehicles2022-01-3105194013core:FurnitureFittings2022-01-3105194013core:OfficeEquipment2022-01-3105194013core:AfterOneYear2022-01-3105194013core:WithinOneYear2022-01-3105194013core:ListedExchangeTraded2022-01-3105194013core:UnlistedNon-exchangeTraded2022-01-3105194013core:ShareCapital2022-01-3105194013core:SharePremium2022-01-3105194013core:RevaluationReserve2022-01-3105194013core:OtherReservesSubtotal2022-01-3105194013core:RetainedEarningsAccumulatedLosses2022-01-3105194013core:NetGoodwill2021-02-0105194013core:IntangibleAssetsOtherThanGoodwill2021-02-0105194013core:LandBuildings2021-02-0105194013core:PlantMachinery2021-02-0105194013core:Vehicles2021-02-0105194013core:FurnitureFittings2021-02-0105194013core:OfficeEquipment2021-02-0105194013core:AfterOneYear2021-02-0105194013core:WithinOneYear2021-02-0105194013core:ListedExchangeTraded2021-02-0105194013core:UnlistedNon-exchangeTraded2021-02-0105194013core:ShareCapital2021-02-0105194013core:SharePremium2021-02-0105194013core:RevaluationReserve2021-02-0105194013core:OtherReservesSubtotal2021-02-0105194013core:RetainedEarningsAccumulatedLosses2021-02-0105194013core:AfterOneYear2022-02-012023-01-3105194013core:WithinOneYear2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:CostValuation2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-012023-01-3105194013core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3105194013core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3105194013core:Non-currentFinancialInstrumentscore:CostValuation2022-01-3105194013core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-01-3105194013core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-01-3105194013bus:Director12022-02-012023-01-3105194013bus:Director22022-02-012023-01-31

DOVE CARE LIMITED

Registered Number
05194013
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2023

DOVE CARE LIMITED
Company Information
for the year from 1 February 2022 to 31 January 2023

Directors

AMBACH-DAVIS, Calum John
DAVIS, Julie

Registered Address

23 Dove House 23 Second Avenue
Upton
Pontefract
WF9 1BW

Registered Number

05194013 (England and Wales)
DOVE CARE LIMITED
Balance Sheet as at
31 January 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets5104,400104,400
Tangible assets6530,252531,060
634,652635,460
Current assets
Debtors725,32833,427
Cash at bank and on hand82,072101,532
107,400134,959
Creditors amounts falling due within one year8(94,176)(22,412)
Net current assets (liabilities)13,224112,547
Total assets less current liabilities647,876748,007
Creditors amounts falling due after one year9(367,460)(492,568)
Net assets280,416255,439
Capital and reserves
Called up share capital22
Profit and loss account280,414255,437
Shareholders' funds280,416255,439
The financial statements were approved and authorised for issue by the Board of Directors on 6 September 2023, and are signed on its behalf by:
DAVIS, Julie
Director
Registered Company No. 05194013
DOVE CARE LIMITED
Notes to the Financial Statements
for the year ended 31 January 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
4.Employee information

20232022
Average number of employees during the year2929
5.Intangible assets

Other

Total

££
Cost or valuation
At 01 February 22104,400104,400
At 31 January 23104,400104,400
Net book value
At 31 January 23104,400104,400
At 31 January 22104,400104,400
6.Property, plant and equipment

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 February 22690,64220,896711,538
At 31 January 23690,64220,896711,538
Depreciation and impairment
At 01 February 22160,88119,597180,478
Charge for year483325808
At 31 January 23161,36419,922181,286
Net book value
At 31 January 23529,278974530,252
At 31 January 22529,7611,299531,060
7.Debtors

2023

2022

££
Amounts owed by associates and joint ventures / participating interests25,32833,427
Total25,32833,427
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
8.Creditors within one year

2023

2022

££
Trade creditors / trade payables11,9629,469
Bank borrowings and overdrafts67,033-
Taxation and social security15,18112,943
Total94,17622,412
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
9.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts367,460492,568
Total367,460492,568